8 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult ParticipantsChemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorderNot yet recruitingEarly phase 12026-10-05NCT07602335
Safety of MOON101 for the Treatment of Peanut AllergyHypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorderActive, not recruitingPhase 12026-10-05NCT07580898
Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male ParticipantsHealthy Male ParticipantsRecruitingPhase 12026-09-25NCT07744802
Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid UsersHealthy, Non-Drug- Dependent, Recreational Opioid UsersRecruitingPhase 42026-09-10NCT07813026
Study of Midomafetamine in Healthy AdultsHealthy VolunteersActive, not recruitingPhase 12026-06-29NCT07584720
Pharmacokinetics of Zelquistinel in Fasted or Fed StateHealthy Volunteers in Fed and Fasted StateActive, not recruitingPhase 12026-03-20NCT07099989
Abuse Liability for Five Modern Oral Nicotine ProductsSmoking; Smoking Behaviors; Tobacco Smoking; Tobacco UseRecruitingNot applicable2025-12-30NCT07132814
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy SmokersArterial Occlusive Diseases, Chemically-Induced Disorders, cardiovascular disorder, nicotine dependence, psychiatric disorder, substance-related disorder, thromboangiitis obliterans, vascular disorder, vasculitisRecruitingPhase 12025-10-15NCT07215923